DFPG Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-16,613
Closed -$1.03M 184
2020
Q3
$1.03M Buy
16,613
+11,310
+213% +$715K 0.55% 48
2020
Q2
$328K Sell
5,303
-4,753
-47% -$287K 0.2% 110
2020
Q1
$581K Buy
+10,056
New +$619K 0.43% 70

Other funds holding PPH

DFPG Investments's PPH Position: Q4 2020 in Review

DFPG Investments sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2020, closing a stake of 16,613 shares — an estimated $1.03M sold.

DFPG Investments first reported a position in PPH in Q1 2020 and held it in 3 quarters. The position peaked at $1.03M in Q3 2020. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2020.

  • DFPG Investments reported no remaining VanEck Pharmaceutical ETF position as of Q4 2020 after selling out during the quarter.
  • DFPG Investments sold 16,613 VanEck Pharmaceutical ETF shares in Q4 2020, an estimated $1.03M.
  • DFPG Investments first reported a position in VanEck Pharmaceutical ETF in Q1 2020 and held it in 3 quarters.
  • DFPG Investments's VanEck Pharmaceutical ETF position peaked at $1.03M in Q3 2020.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2020.

Based on DFPG Investments's 13F filing for Q4 2020, filed 19 Jan 2021.